Focus
generic drugs
How China Controls Our Vital Medicines and the Health Care Supply Chain: Victor Suarez
Some 80 percent of U.S. vital medicines have precursors originating in China. And 20 percent of active pharmaceutical ingredients are solely sourced from China.
Popular Asthma Inhaler Discontinued, Alternatives Exist
Flovent disappeared Jan. 1, when GSK pulled it. Insurers dropping coverage and Medicaid rule changes likely incentivized the move to protect profits.
Pentagon Taps Independent Lab, Not FDA, to Test Safety of Generic Drugs for Service Members
Most of America’s generic drugs are produced in India and China, where the FDA has limited regulatory and oversight power. The Pentagon now wants to contract with a private firm for quality control.
